ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 100 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2016. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $588,000 | -2.0% | 48,800 | +317.1% | 0.01% | -14.3% |
| Q2 2020 | $600,000 | +192.7% | 11,700 | +80.0% | 0.01% | +133.3% |
| Q1 2020 | $205,000 | -58.6% | 6,500 | -21.7% | 0.00% | -40.0% |
| Q4 2019 | $495,000 | +7.1% | 8,300 | -34.1% | 0.01% | 0.0% |
| Q3 2019 | $462,000 | +111.0% | 12,600 | +168.1% | 0.01% | +66.7% |
| Q2 2019 | $219,000 | -36.9% | 4,700 | -2.1% | 0.00% | -25.0% |
| Q1 2018 | $347,000 | +22.6% | 4,800 | -78.8% | 0.00% | 0.0% |
| Q4 2016 | $283,000 | +16.9% | 22,600 | +29.1% | 0.00% | +33.3% |
| Q3 2016 | $242,000 | – | 17,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,818,835 | $59,618,000 | 21.09% |
| Bellevue Group AG | 4,519,164 | $95,580,000 | 0.93% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,713,176 | $36,234,000 | 0.84% |
| Rhenman & Partners Asset Management AB | 572,267 | $12,103,000 | 0.82% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 64,434 | $1,363,000 | 0.45% |
| Boxer Capital, LLC | 500,000 | $10,575,000 | 0.37% |
| EMC Capital Management | 27,566 | $583,000 | 0.33% |
| WASATCH ADVISORS LP | 3,766,935 | $79,671,000 | 0.32% |
| Avidity Partners Management LP | 400,000 | $8,460,000 | 0.23% |
| Cinctive Capital Management LP | 186,170 | $3,937,000 | 0.18% |